Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-028839

CBO & COO sold 25,000 shares at an average $60.40 ($1,509,971)

  • CBO & COO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2020-05-11 Option exercise +25,000 $5.86 $146,500 45,000 D
Klein Lawrence Otto CBO & COO 2020-05-11 Sale −24,318 $60.38 $1,468,321 20,682 D
Klein Lawrence Otto CBO & COO 2020-05-11 Sale −682 $61.07 $41,650 20,000 D
Derivatives
Klein Lawrence Otto CBO & COO 2020-05-11 Option exercise · Stock Option (Right to Buy) −25,000 38,666 D
Open-market sales · 25,000 sh · avg $60.40 · $1,509,971
Loading xslF345X03/doc4.xml…